Platinum-based photosensitizer with near-infrared aggregation-induced emission for synergistic photodynamic-chemo theranostics
Source abstract
Abstract
Abstract Photodynamic therapy (PDT) is of great interest as an emerging paradigm towards cancer treatment, owing to its advantages of minimal invasiveness and low toxicity. In this work, we incorporated cisplatin into an AIE-based photosensitizer (BT) and achieved a highly efficient antitumor drug (BT-Pt). Possessing AIE characteristics, BT-Pt exhibited NIR fluorescence with large Stokes shift in cells, which can guide the location of the drug. More importantly, the ROS generation efficiency of BT-Pt has extremely been promoted with the fabrication of cisplatin, compared with BT. As a result, BT-Pt demonstrated favorable therapeutic efficacy with a half maximal inhibitory concentration (IC50) value of 1.54 μM for HeLa cells upon white light irradiation, attributed to its synergetic PDT and chemotherapy. The design strategy of such platinated photosensitizer showed great potential in developing multifunctional anticancer drugs with combinatorial photodynamic–chemotherapy, especially when ablating cisplatin resistant cancer cells and hypoxic tumors.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (30)
Show source-provided references
1. Prospects in the application of photodynamic therapy in oral cancer and premalignant lesions10.3390/cancers8090083 ↗
2. Supramolecular photosensitizers rejuvenate photodynamic therapy10.1039/C7CS00594F ↗
3. Clinical development and potential of photothermal and photodynamic therapies for cancer10.1038/s41571-020-0410-2 ↗
4. Photodynamic therapy for cancer10.1038/nrc1071 ↗
5. Photodynamic therapy in cancer treatment - an update review
6. Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy10.1039/C6CS00271D ↗
7. Light-triggered theranostic liposomes for tumor diagnosis and combined photodynamic and hypoxia-activated prodrug therapy10.1016/j.biomaterials.2018.09.033 ↗
8. Nanostructured phthalocyanine assemblies with protein-driven switchable photoactivities for biophotonic imaging and therapy10.1021/jacs.7b05916 ↗
9. An aie-active conjugated polymer with high ros-generation ability and biocompatibility for efficient photodynamic therapy of bacterial infections10.1002/anie.201916704 ↗
10. AIE luminogens for bioimaging and theranostics: from organelles to animals
11. Singlet oxygen production in water: Aggregation and charge-transfer effects10.1021/jp952107s ↗
12. Biomacromolecule-functionalized aiegens for advanced biomedical studies10.1002/smll.201804839 ↗
13. Tuning the singlet-triplet energy gap: a unique approach to efficient photosensitizers with aggregation-induced emission (aie) characteristics10.1039/C5SC01733E ↗
14. Overcoming the achilles' heel of photodynamic therapy10.1039/C6CS00616G ↗
15. Light-activatable liposomes for repetitive on-demand drug release and immunopotentiation in hypoxic tumor therapy10.1016/j.biomaterials.2020.120456 ↗
16. High-efficiency platinum–carbon nanozyme for photodynamic and catalytic synergistic tumor therapy10.1016/j.cej.2020.125797 ↗
17. Aggregation-induced emission luminogens married to 2d black phosphorus nanosheets for highly efficient multimodal theranostics10.1002/adma.202003382 ↗
18. Six birds with one stone: versatile nanoporphyrin for single-laser-triggered synergistic phototheranostics and robust immune activation
19. Transition metal complexes as photosensitizers for integrated cancer theranostic applications10.1016/j.ccr.2020.213355 ↗
20. Au2pt-peg-ce6 nanoformulation with dual nanozyme activities for synergistic chemodynamic therapy/phototherapy10.1016/j.biomaterials.2020.120093 ↗
21. Functionalization of platinum complexes for biomedical applications10.1021/acs.accounts.5b00203 ↗
22. Cisplatin in cancer therapy: molecular mechanisms of action10.1016/j.ejphar.2014.07.025 ↗
23. Visible-light-induced annihilation of tumor cells with platinum–porphyrin conjugates10.1002/anie.201400533 ↗
24. Highly emissive self-assembled bodipy-platinum supramolecular triangles10.1021/jacs.8b04929 ↗
25. Visualization of drug delivery processes using aiegens10.1039/C6SC05421H ↗
26. Bifunctional platinated nanoparticles for photoinduced tumor ablation10.1002/adma.201602738 ↗
27. Multicationic aiegens for unimolecular photodynamic theranostics and two-photon fluorescence bioimaging10.1039/D0QM00119H ↗
28. The triplet excited state of bodipy: formation, modulation and application10.1039/C5CS00364D ↗
29. Photosensitizers with aggregation-induced emission: materials and biomedical applications10.1002/adma.201801350 ↗
30. Molecular engineering to boost aie-active free radical photogenerators and enable high-performance photodynamic therapy under hypoxia10.1002/adfm.202002057 ↗